Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Contineum Therapeutics, Inc. | CMO & Head of Development | Stock Option (right to buy) | 26K | Apr 28, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTNM | Contineum Therapeutics, Inc. | Apr 28, 2025 | 2 | $0 | 4 | Apr 28, 2025 | CMO & Head of Development |
CTNM | Contineum Therapeutics, Inc. | Apr 28, 2025 | 0 | $0 | 3 | Apr 28, 2025 | CMO & Head of Development |